QR-Code

The outbreak fingolimod cardiovascular side effects in relapsing-remitting multiple sclerosis patient: A longitudinal study in an Iranian population

<div><p><strong>BACKGROUND:</strong> Fingolimod (FTY-720) has shown efficacy in relapsing multiple sclerosis (MS), while some side effects of this drug have been recognized that the most important is cardiovascular side effects. The aim of this study was to evaluate the cardiovascular side effects o...

Ausführliche Beschreibung

Gespeichert in:
Bibliografische Detailangaben
Hauptverfasser: Morteza Abdar, Payam Ebrahimifar, Masoud Etemadifar
Format: Artigo
Sprache:Inglês
Veröffentlicht: Vesnu Publications 2017-03-01
Schriftenreihe:ARYA Atherosclerosis
Schlagworte:
Online-Zugang:http://arya.mui.ac.ir/index.php/arya/article/view/1348
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!